VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
PCRX
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
PCRXPacira BioSciences, Inc.
$25.09$987M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksPCRXQuarterly Financials

Pacira BioSciences, Inc. (PCRX) Quarterly Financials

120+ quarters historyFree accessUpdated daily

Pacira BioSciences, Inc. (PCRX) quarterly income statement — complete revenue, gross profit & net income history

PCRX Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21Q2'21
Sales/Revenue177.38M196.87M179.52M181.1M168.92M187.25M168.57M178.02M167.12M181.24M163.93M169.47M160.34M171.96M167.47M169.41M157.99M159.19M127.72M135.59M
Revenue Growth %5%5.14%6.49%1.73%1.08%3.32%2.83%5.05%4.23%5.4%-2.11%0.03%1.49%8.02%31.12%24.94%32.74%21.55%8.71%79.58%
Cost of Goods Sold040.3M34.28M40.87M34.31M39.89M38.86M44.26M47.42M47.69M39.75M48.21M49.02M61.92M50.68M50.63M36.07M39.01M34.65M35.25M
COGS % of Revenue-20.47%19.09%22.57%20.31%21.3%23.05%24.86%28.37%26.31%24.25%28.45%30.57%36.01%30.26%29.88%22.83%24.5%27.13%26%
Gross Profit0156.57M145.24M140.23M134.62M147.37M129.71M133.76M119.7M133.55M124.18M121.26M111.32M110.04M116.79M118.78M121.92M120.19M93.07M100.34M
Gross Margin %-79.53%80.91%77.43%79.69%78.7%76.95%75.14%71.63%73.69%75.75%71.55%69.43%63.99%69.74%70.12%77.17%75.5%72.87%74%
Gross Profit Growth %-100%6.25%11.97%4.84%12.46%10.34%4.46%10.31%7.53%21.37%6.33%2.08%-8.69%-8.44%25.48%18.38%39.05%25.62%6.38%88.61%
Operating Expenses170.47M153.38M138.88M131.73M132.63M122.66M269.24M105.52M106.49M100.38M106.45M81.38M114.41M119.93M95.5M87.55M104.52M115.98M61.64M65.5M
OpEx % of Revenue96.11%77.91%77.36%72.74%78.51%65.51%159.71%59.27%63.72%55.39%64.94%48.02%71.36%69.75%57.03%51.68%66.16%72.85%48.26%48.31%
Selling, General & Admin93.94M101.61M91.8M88.58M86.78M79.61M74.33M68.13M72.03M65.8M67.95M64.85M70.84M63.97M61.28M65M64.26M51.2M47.86M50.81M
SG&A % of Revenue52.96%51.61%51.14%48.91%51.37%42.52%44.1%38.27%43.1%36.31%41.45%38.27%44.18%37.2%36.59%38.37%40.67%32.16%37.47%37.48%
Research & Development28.07M37.45M25.97M28.2M25.34M23.9M19.1M20.34M18.24M19.46M20.83M18.82M17.14M17.5M19.41M26.28M21.61M15.51M11.58M12.57M
R&D % of Revenue15.83%19.02%14.46%15.57%15%12.76%11.33%11.42%10.91%10.74%12.71%11.11%10.69%10.18%11.59%15.51%13.67%9.75%9.06%9.27%
Other Operating Expenses1000K1000K1000K1000K1000K1000K1000K1000K1000K1000K1000K-1000K1000K1000K1000K-1000K1000K1000K1000K1000K
Operating Income6.9M3.19M6.36M8.5M1.99M24.7M-139.53M28.24M13.21M33.17M17.72M39.88M-3.09M-9.89M21.29M31.23M17.39M4.21M31.43M34.84M
Operating Margin %3.89%1.62%3.54%4.69%1.18%13.19%-82.77%15.86%7.91%18.3%10.81%23.53%-1.93%-5.75%12.71%18.44%11.01%2.65%24.61%25.7%
Operating Income Growth %246.83%-87.08%104.56%-69.9%-84.94%-25.52%-887.35%-29.18%527.43%435.27%-16.76%27.67%-117.77%-334.93%-32.27%-10.36%-10.52%-77.58%78.39%587.52%
EBITDA6.9M24.53M27.55M35.82M23.16M45.95M-119.27M47.1M31.64M51.65M36.15M58.93M16.51M20.51M41.49M52.1M37.43M17.28M37.16M39.74M
EBITDA Margin %3.89%12.46%15.35%19.78%13.71%24.54%-70.76%26.46%18.93%28.5%22.06%34.77%10.3%11.93%24.77%30.75%23.69%10.86%29.1%29.31%
EBITDA Growth %-70.2%-46.61%123.1%-23.95%-26.8%-11.05%-429.91%-20.07%91.62%151.81%-12.85%13.11%-55.88%18.7%11.64%31.1%54.09%-27.52%64.02%1941.52%
D&A (Non-Cash Add-back)021.34M21.19M27.32M21.17M21.24M20.25M18.86M18.43M18.48M18.43M19.05M19.6M30.41M20.2M20.86M20.03M13.07M5.73M4.9M
EBIT03.94M13.18M1.92M12.44M29.36M-135.01M39.7M16.27M36.42M19.38M41.03M-17.82M-8.47M11.02M29.97M16.36M3.45M30.9M32.01M
Net Interest Income0-1.08M4.88M313K2.31M1.72M793K1.63M587K37K-698K-1.75M-6.45M-8.26M-8.62M-8.58M-9.97M-10.34M-7.16M-6.8M
Interest Income1.93M2.29M8.53M5.01M6.89M5.55M5.48M4.75M3.9M3.42M2.77M2.11M3.14M2.79M1.23M252K271K79K177K224K
Interest Expense-3.7M3.37M3.65M4.7M4.58M3.83M4.69M3.12M3.32M3.39M3.46M3.87M9.59M11.04M9.86M8.83M10.25M10.42M7.33M7.02M
Other Income/Expense-1.9M-2.62M3.16M-10.43M6.72M822K671K8.34M428K552K-1.12M-2.02M-23.38M-8.18M-19.22M-9.23M-10.1M-10.41M-7.2M-9.2M
Pretax Income5M571K9.52M-1.93M8.71M25.53M-138.86M36.58M13.64M33.72M16.6M37.85M-26.47M-18.07M2.07M22.01M7.29M-6.2M24.23M25.65M
Pretax Margin %2.82%0.29%5.31%-1.06%5.15%13.63%-82.37%20.55%8.16%18.6%10.13%22.34%-16.51%-10.51%1.24%12.99%4.62%-3.89%18.97%18.92%
Income Tax-2.08M-1.07M4.09M2.92M3.89M9.48M4.61M17.7M4.66M8.85M5.74M12.09M-6.94M-7.97M2.76M2.13M466K-1.07M6.57M6.57M
Effective Tax Rate %-41.66%-186.69%42.97%-151.53%44.73%37.16%-3.32%48.38%34.17%26.25%34.59%31.94%26.21%44.09%133.49%9.68%6.39%17.23%27.12%25.6%
Net Income7.08M1.64M5.43M-4.85M4.81M16.04M-143.47M18.89M8.98M24.87M10.86M25.76M-19.54M-10.1M-693K19.88M6.83M-5.13M17.66M19.08M
Net Margin %3.99%0.83%3.03%-2.68%2.85%8.57%-85.11%10.61%5.37%13.72%6.62%15.2%-12.18%-5.87%-0.41%11.73%4.32%-3.22%13.83%14.07%
Net Income Growth %47.13%-89.79%103.79%-125.66%-46.41%-35.5%-1421.29%-26.69%145.96%346.19%1666.81%29.62%-386.12%-96.92%-103.92%4.17%-34.15%-135.34%-86.43%362.5%
Net Income (Continuing)7.08M1.64M5.43M-4.85M4.81M16.04M-143.47M18.89M8.98M24.87M10.86M25.76M-19.54M-10.1M-693K19.88M6.83M-5.13M17.66M19.08M
Discontinued Operations00000000000000000000
Minority Interest00000000000000000000
EPS (Diluted)0.070.040.12-0.110.100.34-3.110.390.190.480.230.51-0.43-0.22-0.020.400.15-0.120.390.42
EPS Growth %-30%-88.24%103.86%-128.21%-47.37%-28.83%-1452.17%-23.53%144.19%317.14%1250%27.5%-386.67%-83.33%-105.13%-4.76%-34.78%-137.5%-86.73%347.06%
EPS (Basic)0.070.040.12-0.110.100.35-3.110.410.190.540.230.56-0.43-0.22-0.020.440.15-0.120.400.43
Diluted Shares Outstanding40.91M42.98M44.46M45.46M46.53M49.04M46.13M50.54M52.19M52.06M52.07M52.05M45.95M45.88M45.83M52.48M46.44M44.59M45.46M45.59M
Basic Shares Outstanding40.46M42.49M44.04M45.46M46.27M46.17M46.13M46.17M46.5M46.44M46.42M46.09M45.95M45.88M45.83M45.5M44.87M44.59M44.48M44.15M
Dividend Payout Ratio--------------------